Vertex Acquires Alpine Immune Sciences for $4.9 Billion to Boost Immunology Trail

1. Vertex Pharmaceuticals has purchased Alpine Immune Sciences for $4.9 billion.
2. The acquisition was announced on Wednesday afternoon, April 10, 2024.
3. This transaction is considered the largest biopharma acquisition of the year thus far.
4. The purchase aims to enhance Vertex's immunology trail within the biopharmaceutical industry.

These details are based on the search results provided, indicating that Vertex Pharmaceuticals has made a significant investment in Alpine Immune Sciences to strengthen its position in the immunology field.